Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.4 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.038 | 0.4 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |